FAB-SEA D227A fusion protein
Alternative Names: SEA D227A bispecific antibody conjugateLatest Information Update: 29 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 14 Apr 1999 New profile
- 14 Apr 1999 Preclinical development for Cancer in Japan (Unknown route)